THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
Patient access to orphan drugs in France | Orphanet Journal of Rare Diseases | Full Text
Association des POIC - La base AMELI a enfin été mise à jour concernant la retrocession de la Trimebutine injectable. Aucune pharmacie centrale ne peut, désormais, refuser de la délivrer (sur prescription
Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France | PLOS ONE
OFFRE D'EMPLOI : Responsable Technico-Commercial en Transit (H/F) - Africa Supply Chain
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France | PLOS ONE
Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre Study - Clinical Gastroenterology and Hepatology
CIP ACL - Nouvelle version des bases de données avril 2019
Nouvelle indemnisation transparente pour les médicaments soumis à ordonnance | Communauté d'achat HSK SA
PDF) Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: Results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
PDF) The economic burden of urinary tract infections in women visiting general practices in France: A cross-sectional survey
Réforme de l'accès dérogatoire aux médicaments (MAJ 24/04/23) - OMEDIT Ile de France
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
Prix des médicaments - Comparaison avec l'étranger 2011, Conférence de presse santésuisse, interpharma et vips 20
Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France | PLOS ONE
Modèle tarifaire équitable | Zur Rose
Marge sur les médicaments - Comparaison avec l'étranger, Conférence de presse santésuisse, 23 novembre 2011
Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France”
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012
THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
Competition From Biosimilars Drives Price Reductions For Biologics In The French Single-Payer Health System | Health Affairs
La base de données médicaments Thériaque - CNHIM
